Merck Animal Division's Dog Flu Treatment Gets Agriculture Department Approval
By Denny Jacob
Merck's animal division said the Agriculture Department has approved its dog flu treatment.
Merck Animal Health's Nobivac NXT Canine Flu H3N2 is expected to be available at veterinary clinics and hospitals nationwide late this summer.
The drugmaker said the product is indicated for the vaccination of healthy dogs eight weeks of age or older against canine influenza H3N2.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
June 25, 2024 16:36 ET (20:36 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Six Sports Betting and iGaming Stocks Trading at a Discount
-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations